Fundraising Fox

Elizabeth Holt

CBO at iOnctura

London, England, United Kingdom

Find your path to Elizabeth

1,625 people in our graph share verified history with Elizabeth — schools, employers, funds. One of them is your warm intro.

About

Elizabeth Holt is Chief Business Officer at iOnctura. She was part of the founding team at Aiolos Bio, where she helped negotiate a licensing deal with Jiangsu Hengrui Pharmaceuticals and supported the company's $245M Series A financing prior to its acquisition by GSK in February 2024; earlier, she served as VP, Head of Corporate Planning & Operations at Gyroscope Therapeutics, which Novartis acquired in February 2022, and worked as an Associate Partner at McKinsey & Company advising on strategy, organization, and M&A in life sciences and healthcare. She holds an MBA from NYU Stern School of Business, an MSc from the London School of Economics, and a BA from Davidson College.

CBO at iOnctura

Intro paths

In turn, Elizabeth can intro founders to iOnctura's investors below.

Co-founders at iOnctura

CPCatherine Pickering
Catherine PickeringCo-Founder & CEO
LVLars van der Veen
Lars van der VeenCo-Founder & CSO

Experience

  1. iOncturaChief Business Officercurrent2025 — present
  2. Aiolos BioCo-Founder and VP, of Corporate Strategy & Operations2023 — 2024Greater London, England, United Kingdom
  3. Tier One BioVP, Corporate Strategy & Operations2022 — 2023Greater London, England, United Kingdom
  4. Gyroscope TherapeuticsVP, Head of Corporate Planning and Operations2020 — 2022
  5. Gyroscope TherapeuticsChief of Staff to the CEO2019 — 2020London Area, United Kingdom
  6. McKinsey & CompanyAssociate Partner2016 — 2019London Area, United Kingdom
  7. McKinsey & CompanyEngagement Manager2014 — 2016London Area, United Kingdom
  8. McKinsey & CompanyAssociate2010 — 2014
  9. Overseas Private Investment CorporationIntern, SME2009
  10. DAIContracts Administrator2007 — 2008
  11. DAI- Bosnia and HerzegovinaOperations Manager2007
  12. DAIGrants Manager- Macedonia2006 — 2007
  13. DAIProject Associate2004 — 2006
  14. Greater Washington Board of TradeProgram Assistant, International Gateway2001 — 2002

Skills & more

International Development6Management Consulting26Business Strategy6Financial Modeling3Due Diligence4Marketing Strategy3Venture Capital4Strategy10

From Elizabeth's professional profile.

Frequently asked questions

Who is Elizabeth Holt?
Elizabeth Holt is Chief Business Officer at iOnctura. She was part of the founding team at Aiolos Bio, where she helped negotiate a licensing deal with Jiangsu Hengrui Pharmaceuticals and supported the company's $245M Series A financing prior to its acquisition by GSK in February 2024; earlier, she served as VP, Head of Corporate Planning & Operations at Gyroscope Therapeutics, which Novartis acquired in February 2022, and worked as an Associate Partner at McKinsey & Company advising on strategy, organization, and M&A in life sciences and healthcare. She holds an MBA from NYU Stern School of Business, an MSc from the London School of Economics, and a BA from Davidson College.
Where does Elizabeth Holt work?
Elizabeth Holt is CBO at iOnctura.
Where did Elizabeth Holt go to school?
Elizabeth Holt studied at NYU Stern School of Business (MBA); The London School of Economics and Political Science (LSE) (MSc, Development Studies); Davidson College (BA).

Same school

Shared employers